🇺🇸 FDA

Drug profile · INN

tagraxofusp-erzs

ELZONRIS

FDA: approved
US status
approved
Patents linked
0
News articles
0

Quick answer

tagraxofusp-erzs (ELZONRIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN tagraxofusp-erzs
Brand ELZONRIS
Route INJECTION
Formulation SOLUTION

Frequently asked questions

What is tagraxofusp-erzs?

tagraxofusp-erzs (ELZONRIS) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for tagraxofusp-erzs?

ELZONRIS is a marketed brand name for tagraxofusp-erzs. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of tagraxofusp-erzs?

tagraxofusp-erzs has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.